 |
 |
May
8, 2006 |
 |
|
 |
Volume
VII, Issue 37 |
 |
|
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
NeWave (OTC
BB: NWWV) Rips Cover Off the Ball- If Only It Were Last Year |
|
NeWave's Q1 numbers are simply
off the charts. The company has lived up to expectations in a major way.
Alas, if it were only last year at this time.
Do you want the good news or the
bad news first? OK- first, the bad news. If the company had delivered these
kinds of results one year ago, we wouldn't have the brain damage we experienced
as the stock swooned from $2 to $.20.
Now- for the good news. Last year's
disappointing numbers equate to opportunity for those looking at the stock
at today's levels.
The NeWave saga has come nearly
full circle. Dramatic growth from '03 into '04 as the company flexed its
marketing muscles and grew exponentially. Expectations were high in '05
for more growth and a turn to profitability. In a reasonably favorable
market for ecommerce companies, the stock traded to a high of nearly $2.25.
'05 comes along and the company opens
a couple of disappointing subsidiaries. Sales drop, losses increase, stock
crashes in October and November of '05.
Last summer the management at NeWave
recognized that had to return to their core business. Their turn around
strategy has been executed admirably. Q1 numbers, found in the 10Q at the
SEC's web site this afternoon, are outstanding.
NeWave is in the business
of putting people in business on the internet. It's a subscription based
model. Slowly but surely they have improved their service, and it is clearly
evident from today's numbers that the company is executing. Here are the
hard facts:
-
Revenues for the quarter were $3,932,343,
up from $1,258,616- a 212% increase.
-
Profits were $194,380, up from a
loss of $1,291,480; That's a turn around of $1.45 million
-
The company reduced its debt by $1
million- to $2.8 million.
Currently, there are 40 million shares
I&O. At Monday's closing price (which I'm sure won't be the opening
price on Tuesday), the market was saying the whole company was only worth
$12
million.
Therefore, at $.30 this now
profitable company growing at a clip of 200% per annum is only trading
at 1x sales.
As you can see from the chart, the
stock has been grinding in a range between $.20 and $.40 since
December. By the time you read this, I'm guessing a major breakout
will have already begun.
Had NWWV delivered these results
in '05 I'm pretty sure we would have made a nice profit in the stock from
the $1.50 range. The stock was ahead of the company. Now, the company is
ahead of the stock. Stay tuned for more growth from here.
If you are going to try to trade
the stock on Tuesday, caution should be used. The inevitable morning surge
will not doubt be followed by a pullback of some sort. Use your common
sense on the trading side.
|
|
Comments in the BLOG
|
There were two new BLOG postings
on Monday which you should review. Firstly, Advanced Cellular (ACTC)
enjoyed a big rebound surge in Monday's trading, fueled by comments on
the company in the Wall Street Journal. The complete text of the
article is in the BLOG. Also, there were comments on US Energy
(HYFS)- a big gainer for us in the early going. If you missed the first
40%
run, now is definitely the time to look at the stock. I believe the
adoption of the company's fuel saving technology is on the verge of major
commercial acceptance.
To use the BLOG, simply go
to the home page at www.otcjournal.com
- the BLOG will scroll down automatically on the right side of your
screen. The most current journal entries appear in the middle of your screen.
Check back frequently for updates particularly when stocks are moving to
overbought or oversold levels in volatile markets. |
|
|
|
 |
Subscribe |
 |
Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription.
Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.
To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best
way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable
email newsletter delivery.
Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.
|
|
|
|
| The OTCjournal.com Newsletter is
an independent electronic publication committed to providing our readers
with factual information on selected publicly traded companies. All
companies are chosen on the basis of certain financial analysis and other
pertinent criteria with a view toward maximizing the upside potential
for investors while minimizing the downside risk, whenever possible.
Moreover, as detailed below, this publication accepts compensation from
certain of the companies which it features. Likewise, this newsletter
is owned by MarketByte, LLC. To the degrees enumerated herein,
this newsletter should not be regarded as an independent publication.
Go
Here to view our compensation on every company we have ever covered,
or visit the following web address: http://www.otcjournal.com/disclaimer.html
for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html
for Trading Alerts. MarketBtye LLC has been paid of fee of $25,000 in cash
and 750,000 newly issued, restricted shares by NeWave for coverage of the
company. All 750,00 have become eligible to be free trading as a result
of a registration statement.
All statements and expressions are
the sole opinions of the editors and are subject to change without notice.
A profile, description, or other mention of a company in the newsletter
is neither an offer nor solicitation to buy or sell any securities
mentioned. While we believe all sources of information to be factual and
reliable, in no way do we represent or guarantee the accuracy thereof,
nor the statements made herein.
From time to time MarketByte LLC
sells shares in the open market it receives as compensation for coverage
of client companies. Since the shares are received as compensation for
services as previously disclosed, and not for investment purposes, the
editors do not view the sale of the shares as contradictory to any advice
delivered in the content. This should be viewed as a conflict of interest
by shareholders or prospective shareholders of the client companies.
The editor, members of the editor's
family, and/or entities with which they are affiliated aside from MarketBtye
LLC itself, are forbidden by company policy to own, buy, sell or otherwise
trade stock for their own benefit in the companies who appear in the publication
unless specifically disclosed in the newsletter. Some of the companies
featured in the OTC Journal pay a cash ESP fee to an affiliated technology
company ranging from $2,000 to $5,000 per month for internet related technology
services.
The Trustee of the MarketByte LLC
Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested
approximately $140,0000 in Dutchess Private Equities II LP (“the Dutchess
Limited Partnership”), a limited partnership in which the MarketByte Pension
Plan is a limited partner. The Trustee of the MarketByte LLC Defined Benefit
and Trust (“the MarketByte Pension Plan”) has invested approximately $190,0000
in the Longview Fund (“the Longview Limited Partnership”), both limited
partnerships in which the MarketByte Pension Plan is a limited partner.
No one associated with the MarketByte Pension Plan has any knowledge, information,
or control as to any past, present, or future investment activities of
the Dutchess Limited Partnership or the Longview Fund. The Dutchess
Limited Partnership is one of two hedge funds managed by Dutchess Advisors.
Dutchess Advisors and Longview periodically refers companies to MarketByte
LLC for possible coverage by one of the MarketByte LLC publications, which
publications include The OTCJournal.com Newsletter. Dutchess Advisors
or Longview may or may not own shares in the companies that it so refers
to MarketByte. MarketByte has no information (outside of information readily
accessible to the general public such as SEC filings) as to whether Dutchess
Advisors or Longview owns any shares in the companies that it refers to
MarketByte LLC. The above relationships should be viewed as a potential
and/or actual conflict of interest by shareholders and prospective shareholders
of MarketByte LLC client companies.
The profiles, critiques, and other
editorial content of the OTCjournal.com may contain statements that appear
foward relating to the expected capabilities of the companies mentioned
herein.
THE READER SHOULD VERIFY ALL CLAIMS
AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED.
INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE
OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT
LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY
WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.
We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or
the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Disclaimer ID:$subst('Recip.userid') Readers can review all public filings
by companies at the SEC's EDGAR page. The NASD has published information
on how to invest carefully at its web site. MarketByte LLC's mailing
address is 3525 Del Mar Heights Rd #334, San Diego, CA 92130.
You
can unsubscribe from this list at any time by Clicking
Here. If you are having difficulty removing yourself or wish to change
your address please go to http://www.otcjournal.com/opt.html?. |
|
|
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.

|